Nuvation Bio Inc (NUVB) Stock Forecast & Price Target
Nuvation Bio Inc · NYSE
$6.61-0.20 (-3.01%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Nuvation Bio Inc, 9 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. The target range is very wide, $7.00 to $21.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $13.00 sits 97% above the current $6.61. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 7 to 8 over recent months. On the fundamentals, the Street sees consensus EPS building from about $-0.09 next quarter toward $-0.01 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Strong Buy
Strong Buy00%
Buy990%
Hold110%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Nuvation Bio Inc.
As of Sep, 8 of 9 firms rate NUVB a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
NUVB EPS & revenue forecast
EPS · NEXT QUARTER
$-0.09
Range $-0.09 – $-0.09 · 2 analysts · +5% YoY
Next period, 2 analysts expect Nuvation Bio Inc to earn $-0.09 a share (range $-0.09 – $-0.09), versus $-0.09 a year earlier. Full-year consensus is $-0.29, growing to $-0.01 the year after.
REVENUE · NEXT QUARTER
$48.5M
Range $33.4M – $69.1M · 2 analysts · +16% YoY
Revenue is expected to reach $48.5M (range $33.4M – $69.1M), +15.9% year-over-year. Full-year consensus is $199.1M, rising to $282.4M next year.
Top analysts covering Nuvation Bio Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NUVB.
#1
Silvan Tuerkcan
JMP Securities · Rank #26
Buy
$10.00+51.4% to target
Overall win rate
53%
+ Follow
#2
Leonid Timashev
RBC Capital · Rank #33
Buy
$20.00+202.8% to target
Overall win rate
48%
+ Follow
#3
Mayank Mamtani
B. Riley Securities · Rank #41
Buy
$14.00+112.0% to target
Overall win rate
50%
+ Follow
#4
David Nierengarten
Wedbush · Rank #66
Buy
$11.00+66.5% to target
Overall win rate
42%
+ Follow
#5
RB
Robert Burns
HC Wainwright & Co. · Rank #199
Buy
$21.00+217.9% to target
Overall win rate
41%
+ Follow
NUVB stock forecast FAQ
What is NUVB's average 12-month price target?+
The 9 analysts with a live target average $13.00 for Nuvation Bio Inc over the next 12 months, ranging from a $21.00 high to a $7.00 low.
Is NUVB stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for NUVB?+
The Street-high target is $21.00 (HC Wainwright & Co.), and the Street-low is $7.00 (UBS). The average of all 9 active targets is $13.00.
How many Wall Street analysts cover NUVB?+
10 analysts have an active rating on Nuvation Bio Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering NUVB?+
Among analysts who currently cover NUVB, Silvan Tuerkcan of JMP Securities has the strongest overall Quantellect track record (Rank #26). Their current call is Buy with a $10.00 target.
What is Nuvation Bio Inc's projected EPS for next quarter?+
The consensus estimate is $-0.09 per share (range $-0.09 – $-0.09) across 2 analysts. Full-year EPS is projected at $-0.29, rising to $-0.01 the following year.
How much revenue is Nuvation Bio Inc expected to report next quarter?+
Consensus revenue is $48.5M (range $33.4M – $69.1M). Full-year revenue is projected at $199.1M, growing to $282.4M next year.
Have analysts been upgrading or downgrading NUVB lately?+
As of Sep, 8 of 9 firms rate NUVB a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NUVB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
